
Thomas H. Kean Jr.
RHouseRepresentative · New Jersey
Sold up to $50,000 of Johnson & Johnson (JNJ)
Trade dated Jan 23, 202627 days to disclose
JNJ since the sale
+3.6%
S&P 500, same window
+9.8%
▼ JNJ trailed the S&P 500 by 6.2 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
⚑ Committee jurisdiction
Thomas H. Kean Jr. sits on Energy and Commerce, which oversees the Pharmaceutical sector. This trade fell in that sector while Thomas H. Kean Jr. held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Dec 10, 2025CommitteePutting Families First: Strengthening CHAMPVA for Survivors and Dependents
- Dec 17, 2025Floor voteResult: Failed
- Dec 17, 2025Floor voteResult: Passed
- Dec 18, 2025Floor voteResult: Failed
- Dec 18, 2025Floor voteResult: Passed
- Jan 7, 2026LegislationPharmaceutical sector
- Jan 14, 2026CommitteeOversight of the Federal Communications Commission
- Jan 15, 2026LegislationPharmaceutical sector
- Jan 22, 2026LegislationPharmaceutical sector
- Jan 23, 2026TradeSold up to $50,000 of JNJ
- Jan 30, 2026LegislationPharmaceutical sector
- Feb 3, 2026LegislationPharmaceutical sector
- Feb 19, 2026DisclosureDisclosed the tradePublic filing
- Mar 5, 2026CommitteeHidden Wounds: Effectively Supporting Veterans with TBI
- Apr 16, 2026Floor voteResult: Passed
Get an alert the moment Thomas H. Kean Jr. files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.